# Radio-Immuno-Modulation in Lung Cancer

> **NCT02579005** · PHASE1 · SUSPENDED · sponsor: **Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal** · enrollment: 24 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** Patients with a living donor
- **BIOLOGICAL:** Patients with a UCB donor

## Key facts

- **NCT ID:** NCT02579005
- **Lead sponsor:** Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-04-20
- **Primary completion:** 2024-10
- **Final completion:** 2025-04
- **Target enrollment:** 24 (ESTIMATED)
- **Why stopped:** Lack of ressources
- **Last updated:** 2024-02-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02579005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02579005, "Radio-Immuno-Modulation in Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02579005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*